Notes
Relypsa Inc
Reference
Bounthavong M, et al. Assessing the Cost-Effectiveness of Patiromer plus Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PCV69, May 2017. Available from: URL: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/71207?pdfid=50210
Rights and permissions
About this article
Cite this article
Adding patiromer to spironolactone cost effective for HF. PharmacoEcon Outcomes News 780, 6 (2017). https://doi.org/10.1007/s40274-017-4058-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4058-9